Sarah Boyce
President and Chief Executive Officer, Avidity Biosciences
We understand that the nervous, immune and inflammatory systems are often linked together. Many diseases arise when these connections fall out of balance. By modulating and restoring function to these critical pathways, we aim to modify disease progression and help patients reclaim their health.
Since Our Founding
Our mission is to make a meaningful difference in the clinical disability associated with neurology, inflammation and immunology (NI&I) diseases. Today, we are advancing our pipeline of promising, small molecule drug candidates into multiple clinical trials.
Contineum Strengths
A continuous team
We have a strong, complementary relationship between our medicinal chemistry, biology, DMPK and clinical teams, which fosters the development of differentiated drug candidates to treat diseases of high unmet need.
De-risked targets
Many of our targets have been validated in both preclinical and clinical research settings.
Broadening our reach
We harness our drug discovery capabilities to build a franchise with a deliberate focus on developing therapeutics that are synergistic with our existing portfolio.
Better together
Collaborations can help accelerate the delivery of effective therapies to the patient. Our partners play a key role in contributing to the development and commercialization of our therapeutic portfolio.
Leadership
Board of Directors
Todd Brady
Director of Finance and Investments, Brace Pharma Capital
Troy Ignelzi
Chief Financial Officer, Rapport Therapeutics, Inc.
Lori Lyons-Williams
President and Chief Executive Officer, Abdera Therapeutics, Inc.
Dr. Diego Miralles
Chief Executive Officer, AZURNA Therapeutics, Inc.
Evert Schimmelpennink
President and Chief Executive Officer, LENZ Therapeutics
Carmine Stengone
President and Chief Executive Officer
Olivia Ware
Former SVP, Principia Biopharma
Carmine Stengone
/in Board of Directors, Leadership/by David AndersonPresident and Chief Executive Officer
Austin Chen, PhD
/in Leadership/by David AndersonSenior Vice President, Head of Research
Beverly Dixon
/in Leadership/by David AndersonSenior Director, Quality Assurance
Kristina Haeckl
/in Leadership/by David AndersonSr. Vice President, Regulatory Affairs
Daniel Lorrain, PhD
/in Leadership/by David AndersonChief Scientific Officer
Jennifer Patterson
/in Leadership/by David AndersonVice President, Human Resources
John Healy
/in Leadership/by David AndersonGeneral Counsel & Corporate Secretary
Jon Seiders, PhD
/in Leadership/by David AndersonVice President, CMC
Jules Lee
/in Leadership/by David AndersonSenior Director, Clinical Operations
Julie Iwashita
/in Leadership/by David AndersonSenior Vice President, Clinical Operations
Karin Stebbins
/in Leadership/by David AndersonVice President, Toxicology
Marietta Franco
/in Leadership/by David AndersonExecutive Director, Clinical Operations
Michael Mayberry
/in Leadership/by David AndersonVice President, Finance
Mike Poon, PhD
/in Leadership/by David AndersonVice President, Biology
Mudiaga Sowho, MD, MPH
/in Leadership/by David AndersonSenior Medical Director
Peter Slover
/in Leadership/by David AndersonChief Financial Officer
Steve Kunszabo
/in Leadership/by David AndersonSenior Director, Investor Relations & Corporate Communications
Tara Vargas
/in Leadership/by David AndersonSenior Director, Project Management
Thomas O. Schrader, PhD
/in Leadership/by David AndersonSenior Director, Chemistry
Timothy Watkins, MD, MSc
/in Leadership/by David AndersonCMO & Head of Development
Varsha Dourado
/in Leadership/by David AndersonVice President, Business Development
Yun Hardiman
/in Leadership/by David AndersonVice President, Head of Biometrics